The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Mutations in Regulatory Subunit Type 1A of Cyclic Adenosine 5′-Monophosphate-Dependent Protein Kinase (PRKAR1A): Phenotype Analysis in 353 Patients and 80 Different Genotypes
Open accessAbstract
BACKGROUND: The "complex of myxomas, spotty skin pigmentation, and endocrine overactivity," or "Carney complex" (CNC), is caused by inactivating mutations of the regulatory subunit type 1A of the cAMP-dependent protein kinase (PRKAR1A) gene and as yet unknown defect(s) in other gene(s). Delineation of a genotype-phenotype correlation for CNC patients is essential for understanding PRKAR1A function and providing counseling and preventive care. METHODS: A transatlantic consortium studied the molecular genotype and clinical phenotype of 353 patients (221 females and 132 males, age 34 +/- 19 yr) who carried a germline PRKAR1A mutation or were diagnosed with CNC and/or primary pigmented nodular adrenocortical disease. RESULTS: A total of 258 patients (73%) carried 80 different PRKAR1A mutations; 114 (62%) of the index cases had a PRKAR1A mutation. Most PRKAR1A mutations (82%) led to lack of detectable mutant protein (nonexpressed mutations) because of nonsense mRNA mediated decay. Patients with a PRKAR1A mutation were more likely to have pigmented skin lesions, myxomas, and thyroid and gonadal tumors; they also presented earlier with these tumors. Primary pigmented nodular adrenocortical disease occurred earlier, was more frequent in females, and was the only manifestation of CNC with a gender predilection. Mutations located in exons were more often associated with acromegaly, myxomas, lentigines, and schwannomas, whereas the frequent c.491-492delTG mutation was commonly associated with lentigines, cardiac myxomas, and thyroid tumors. Overall, nonexpressed PRKAR1A mutations were associated with less severe disease. CONCLUSION: CNC is genetically and clinically heterogeneous. Certain tumors are more frequent, with specific mutations providing some genotype-phenotype correlation for PRKAR1A mutations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kirschner, L. S., Carney, J. A., Pack, S. D., Taymans, S. E., Giatzakis, C., Cho, Y. S., Cho-Chung, Y. S., & Stratakis, C. A. (2000) · Nature Genetics · doi:10.1038/79238 · Cited by 1,153
Self-citationThe Complex of Myxomas, Spotty Pigmentation, and Endocrine Overactivity
CARNEY, J. A., GORDON, H., CARPENTER, P. C., SHENOY, B. V., & W. GO, V. L. (1985) · Medicine · doi:10.1097/00005792-198507000-00007 · Cited by 1,114
Self-citationManagement of the clinically inapparent adrenal mass ("incidentaloma")
Grumbach, M. M., Biller, B. M. K., Braunstein, G. D., Campbell, K. K., Carney, J. A., Godley, P. A., Harris, E. L., Lee, J. K. T., Oertel, Y. C., Posner, M. C., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-5-200303040-00013 · Cited by 945
Self-citationStratakis, C. A., Kirschner, L. S., & Carney, J. A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.9.4041 · Cited by 826
Self-citationStratakis, C. A., Carney, J. A., Lin, J. P., Papanicolaou, D. A., Karl, M., Kastner, D. L., Pras, E., & Chrousos, G. P. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118467 · Cited by 459
Self-citationKirschner, L. S. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.20.3037 · Cited by 402
Self-citationHorvath, A., Boikos, S., Giatzakis, C., Robinson-White, A., Groussin, L., Griffin, K. J., Stein, E., Levine, E., Delimpasi, G., Hsiao, H. P., et al. (2006) · Nature Genetics · doi:10.1038/ng1809 · Cited by 352
Self-citationCarney complex: The complex of myxomas, spotty pigmentation, endocrine overactivity, and schwannomas
Carney, J. A. (1995) · Seminars in Dermatology · doi:10.1016/s1085-5629(05)80003-3 · Cited by 209
Self-citationGroussin, L., Kirschner, L. S., Vincent-Dejean, C., Perlemoine, K., Jullian, E., Delemer, B., Zacharieva, S., Pignatelli, D., Carney, J. A., Luton, J. P., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/344579 · Cited by 192
Self-citationMutation in PDE8B,a Cyclic AMP–Specific Phosphodiesterase in Adrenal Hyperplasia
Horvath, A., Mericq, V., & Stratakis, C. A. (2008) · New England Journal of Medicine · doi:10.1056/nejmc0706182 · Cited by 190
Self-citationCarney complex: the first 20 years
Boikos, S. A., & Stratakis, C. A. (2007) · Current Opinion in Oncology · doi:10.1097/cco.0b013e32801195eb · Cited by 180
Self-citationKirschner, L. S., Kusewitt, D. F., Matyakhina, L., Towns, W. H., Carney, J. A., Westphal, H., & Stratakis, C. A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0580 · Cited by 175
Self-citationThe Essential Role of RIα in the Maintenance of Regulated PKA Activity
AMIEUX, P. S., & MCKNIGHT, G. S. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04328.x · Cited by 164
Veugelers, M., Wilkes, D. C., Burton, K. A., McDermott, D. A., Song, Y., Goldstein, M. M., Perle, K. L., Vaughan, C. J., O'Hagan, A. H., Bennett, K. R., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405535101 · Cited by 163
Chromosome 2 (2p16) abnormalities in Carney complex tumours
Matyakhina, L., Pack, S., Kirschner, L. S., Pak, E., Mannan, P., Jaikumar, J., Taymans, S. E., Sandrini, F., Carney, J. A., & Stratakis, C. A. (2003) · Journal of Medical Genetics · doi:10.1136/jmg.40.4.268 · Cited by 135
Self-citationAPRKAR1AMutation Associated with Primary Pigmented Nodular Adrenocortical Disease in 12 Kindreds
Groussin, L., Horvath, A., Jullian, E. H., Boikos, S. A., René-Corail, F., Lefèbvre, H., Cephise-Velayoudom, F.-L., Vantyghem, M., Chanson, P., Conte‐Devolx, B., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2708 · Cited by 134
Self-citationHorvath, A., Giatzakis, C., Robinson-White, A. J., Boikos, S. A., Levine, E., Griffin, K., Stein, E. V., Kamvissi, V., Soni, P., Bossis, I., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2914 · Cited by 118
Self-citationGriffin, K., Kirschner, L. S., Matyakhina, L., Stergiopoulos, S. G., Robinson-White, A., Lenherr, S. M., Weinberg, F. D., Claflin, E. S., Batista, D., Bourdeau, I., et al. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2004.028043 · Cited by 113
Self-citationMavrakis, M., Lippincott‐Schwartz, J., Stratakis, C. A., & Bossis, I. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl239 · Cited by 111
Self-citationLarge Deletions of the PRKAR1A Gene in Carney Complex
Horvath, A., Bossis, I., Giatzakis, C., Levine, E., Weinberg, F. D., Meoli, E., Robinson-White, A. J., Siegel, J., Soni, P., Groussin, L., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1155 · Cited by 110
Self-citationGriffin, K., Kirschner, L. S., Matyakhina, L., Stergiopoulos, S. G., Robinson-White, A. J., Lenherr, S. M., Weinberg, F. D., Claflin, E. S., Meoli, E., Cho‐Chung, Y. S., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-3620 · Cited by 97
Self-citationRobinson-White, A. J. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg160 · Cited by 89
Disruption of Protein Kinase A Regulation Causes Immortalization and Dysregulation of D-Type Cyclins
Nadella, K. S., & Kirschner, L. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-3183 · Cited by 73
Self-citationPRKAR1A mutations in primary pigmented nodular adrenocortical disease
Cazabat, L., Ragazzon, B., Groussin, L., & Bertherat, J. Y. (2006) · Pituitary · doi:10.1007/s11102-006-0266-1 · Cited by 71
Self-citationGreene, E., Horvath, A., Nesterova, M., Giatzakis, C., Bossis, I., & Stratakis, C. A. (2008) · Human Mutation · doi:10.1002/humu.20688 · Cited by 69
Self-citationAutoantibody Cancer Biomarker: Extracellular Protein Kinase A
Nesterova, M. V., Johnson, N. R., Cheadle, C., Bates, S. E., Mani, S., Stratakis, C. A., Kahn, I., Gupta, R. K., & Cho‐Chung, Y. S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1049 · Cited by 65
Self-citationProtein Kinase A Effects of an Expressed PRKAR1A Mutation Associated with Aggressive Tumors
Meoli, E., Bossis, I., Cazabat, L., Mavrakis, M., Horvath, A., Stergiopoulos, S., Shiferaw, M. L., Fumey, G., Perlemoine, K., Muchow, M., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0064 · Cited by 63
Self-citationStratakis, C. A. (2007) · Hormone and Metabolic Research · doi:10.1055/s-2007-981477 · Cited by 62
Self-citationLiu, J., Matyakhina, L., Han, Z. J., Sandrini, F., Bei, T. A., Stratakis, C. A., & Papadopoulos, V. (2003) · The FASEB Journal · doi:10.1096/fj.02-1066fje · Cited by 45
Self-citationPRKAR1A Inactivation Leads to Increased Proliferation and Decreased Apoptosis in Human B Lymphocytes
Robinson-White, A. J., Leitner, W. W., Aleem, E. A., Kaldis, P., Bossis, I., & Stratakis, C. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2200 · Cited by 40
Self-citationcAMP PATHWAY ALTERATIONS FROM THE CELL SURFACE TO THE NUCLEUS IN ADRENOCORTICAL TUMORS
Rosenberg, D., Groussin, L., BERTAGNA, X. Y., & Bertherat, J. Y. (2002) · Endocrine Research · doi:10.1081/erc-120017071 · Cited by 30
Self-citationMale infertility as a component of Carney complex
Wieacker, P. F., Stratakis, C. A., Horvath, A., Klose, S., Nickel, I., & Muschke, P. (2007) · Andrologia · doi:10.1111/j.1439-0272.2007.00784.x · Cited by 24
Self-citationCarney Complex--Clarity and Complexity
Malchoff, C. D. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.11.4010 · Cited by 10
A Japanese Case of Familial Cardiac Myxoma Associated with a Mutation of the PRKAR1.ALPHA. Gene
Kojima, S., Sumiyoshi, M., Watanabe, Y., Suwa, S., Matsumoto, M., Nakata, Y., & Daida, H. (2005) · Internal Medicine · doi:10.2169/internalmedicine.44.607 · Cited by 8
A New Inherited Syndrome With Cardiac, Cutaneous, and Endocrine Involvement
Michels, V. V. (1986) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)61854-0 · Cited by 3
Research works printed but not linked: 4
- OMIM no. 160980. http://www.ncbi.nlm.nih.gov/omim/
- Conroy, 2004, Atrial myxoma: a cardiocutaneous syndrome., Hosp Med, 65, 56, 10.12968/hosp.2004.65.1.2423 · doi:10.12968/hosp.2004.65.1.2423
- Skamrov, 2003, [PRKAR1A gene mutations in two patients with myxoma syndrome (Carney complex)]., Kardiologiia, 43, 77
- Yoon, 2003, A typical Korean case of Carney complex., Korean J Intern Med, 18, 260, 10.3904/kjim.2003.18.4.260 · doi:10.3904/kjim.2003.18.4.260
Cited by
Lacroix, A., Feelders, R. A., Stratakis, C. A., & Nieman, L. K. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61375-1 · Cited by 1,777
Self-citationFrancis, G. L., Waguespack, S. G., Bauer, A. J., Angelos, P., Benvenga, S., Cerutti, J. M., Dinauer, C. A., Hamilton, J., Hay, I. D., Luster, M., et al. (2015) · Thyroid · doi:10.1089/thy.2014.0460 · Cited by 1,238
Hampel, H., Bennett, R. L., Buchanan, A., Pearlman, R., & Wiesner, G. L. (2015) · Genetics in Medicine · doi:10.1038/gim.2014.147 · Cited by 587
Patel, K. N., Yip, L., Lubitz, C. C., Grubbs, E. G., Miller, B. S., Shen, W., Angelos, P., Chen, H., Doherty, G. M., Fahey, T. J., et al. (2020) · Annals of Surgery · doi:10.1097/sla.0000000000003580 · Cited by 541
Daly, A. F., Tichomirowa, M. A., Petrossians, P., Heliövaara, E., Jaffrain-Rea, M.-L., Barlier, A., Naves, L. A., Ebeling, T., Karhu, A., Raappana, A., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2556 · Cited by 384
Self-citation
Metadata
- Authors
- Bertherat, J., Horvath, A., Groussin, L., Grabar, S., Boikos, S., Cazabat, L., Libe, R., René-Corail, F., Stergiopoulos, S., Bourdeau, I., Bei, T., Clauser, E., Calender, A., Kirschner, L. S., Bertagna, X., Carney, J. A., & Stratakis, C. A.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2009-06-01
- Volume
- 94
- Issue
- 6
- Pages
- 2085-2091
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2095849867
- Cited by
- 449
- References
- 35
- FWCI
- 24.60
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.